top of page

Decoding Alzheimer's Disease:
A breakthrough in
Blood-Based Biomarkers

Blood based biomarkers

The world's leading technology for 22 multi-protein blood analysis

Alzheimer's Disease-associated blood-based biomarkers. 

Image by Markus Spiske

Proprietary machine
learning algorithm

Accurately detects the risk of AD in a disease stage dependent manner.

​Proprietary machine learning algorithm
​Proven in clinical trial of 1000+ patients

Proven in clinical trial
of 1000+ patients

Validated in multiple ethnicity patients.

抽象的線性背景

AI-Powered
comprehensive analysis

Disease monitoring and staging

ai powered comprehensive analysis
exclusively licensed

Exclusively Licensed
by a top-tier local university

Leveraging over 30 years of research data 

bottom of page